Adalimumab/infliximabMelanoma: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1624卷 / 1期

关键词：

D O I：

10.1007/s40278-016-22224-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：18 / 18

相关论文

共 50 条

[21] Adalimumab/infliximab/ustekinumabHerpes zoster: 4 case reports
Reactions Weekly, 2015, 1547 (1) : 16 - 16
[22] Adalimumab/etanercept/infliximabSkin reactions: 4 case reports
Reactions Weekly, 2012, 1417 (1) : 6 - 6
[23] Immunosuppressants/adalimumab/infliximabVisual loss: 4 case reports
Reactions Weekly, 2016, 1591 (1) : 103 - 103
[24] Adalimumab/etanercept/infliximabSkin reactions: 4 case reports
Reactions Weekly, 2009, 1260 (1) : 6 - 6
[25] Adalimumab/azathioprine/infliximabReactivation of TB: 4 case reports
Reactions Weekly, 2019, 1762 (1) : 17 - 17
[26] Adalimumab/infliximab/methotrexateVarious toxicities: 4 case reports
Reactions Weekly, 2019, 1753 (1) : 14 - 14
[27] Adalimumab/etanercept/infliximabPulmonary and gastrointestinal tuberculosis: 4 case reports
Reactions Weekly, 2015, 1554 (1) : 17 - 17
[28] Adalimumab/infliximab/rituximabVarious hypersensitivity reactions: 4 case reports
Reactions Weekly, 2015, 1543 (1) : 19 - 19
[29] Adalimumab/infliximab/rituximabVarious hypersensitivity reactions: 4 case reports
Reactions Weekly, 2014, 1530 (1) : 21 - 21
[30] Adalimumab/certolizumab-pegolVarious myelopathies: 4 case reports
Reactions Weekly, 2017, 1644 (1) : 14 - 14

← 1 2 3 4 5 →